Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Hospital emergency departments play growing role in US health care system

Hospital emergency departments play a growing role in the U.S. health care system, accounting for a rising proportion of hospital admissions and serving increasingly as an advanced diagnostic center for primary care physicians, according to a new RAND Corporation study.

21 May 2013

EHRA EUROPACE 2013 to feature late breaking clinical trials

Attendees will have the opportunity to hear the results of cutting edge studies, and to learn about the new Guidelines which are likely to have a tremendous impact on the European health care system.

18 May 2013

Heart failure patients may have high risk of death, re-admission after leaving hospital, say researchers

Heart attack or heart failure patients may have a high risk of death or re-admission for a month or longer after leaving the hospital, researchers said at the American Heart Association's Quality of Care and Outcomes Scientific Sessions 2013.

17 May 2013

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).

16 May 2013

Simponi injection gets FDA approval to treat adults with ulcerative colitis

The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

16 May 2013

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.

15 May 2013

New studies support previous findings that reducing dietary sodium intake improves health

Recent studies that examine links between sodium consumption and health outcomes support recommendations to lower sodium intake from the very high levels some Americans consume now, but evidence from these studies does not support reduction in sodium intake to below 2,300 mg per day, says a new report from the Institute of Medicine.

15 May 2013

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).

15 May 2013

Study shows dual-chamber ICDs are associated with higher risk of device-related complications

Even though patients receiving an implantable cardioverter-defibrillator for primary prevention often receive a dual-chamber ICD, an analysis that included more than 32,000 patients receiving an ICD without indications for pacing finds that the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes, according to a study in the May 15 issue of JAMA.

15 May 2013

Blue Cross Blue Shield Foundation honors Beaumont cardiologist for improving health care in Michigan

Kavitha Chinnaiyan, M.D., director of Advanced Cardiac Imaging Education at Beaumont Hospital, Royal Oak, has received the Frank J. McDevitt, D.O., Award for Excellence in Health Policy Research for Physicians.

14 May 2013

Sorin Group receives FDA approval for SMARTVIEW remote monitoring solution

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, today announced it received FDA approval for and is beginning the U.S. launch of the SMARTVIEW remote monitoring solution for patients with implanted cardiac rhythm management devices.

13 May 2013

New 3-D technology to see precise source of atrial fibrillation in the heart

Researchers at the Intermountain Heart Institute at Intermountain Medical Center have developed a new 3-D technology that for the first time allows cardiologists the ability to see the precise source of atrial fibrillation in the heart - a breakthrough for a condition that affects nearly three million Americans.

13 May 2013

Private insurers have cost Medicare almost $300 billion more over the life of the program

A study published online today finds that the private insurance companies that participate in Medicare under the Medicare Advantage program and its predecessors have cost the publicly funded program for the elderly and disabled an extra $282.6 billion since 1985, most of it over the past eight years. In 2012 alone, private insurers were overpaid $34.1 billion.

13 May 2013

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left… until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart.

9 May 2013

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.

9 May 2013

Researchers discover that microRNAs link two defining characteristics of fit muscles

Researchers discovered that small pieces of genetic material called microRNAs link the two defining characteristics of fit muscles: the ability to burn sugar and fat and the ability to switch between slow- and fast-twitch muscle fibers.

9 May 2013

BIOTRONIK receives FDA approval for ICD/CRT-D series

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that the Food and Drug Administration granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator series.

8 May 2013

National Transitions of Care Coalition cites patient education as key component of post hospital health management, disease prevention framework

The National Transitions of Care Coalition has cited patient education as a required component of post hospital health management and disease prevention framework. Today's technologies and digital delivery options allows health providers to target reductions in re-admissions, and emergency department visits, while improving patient compliance and patient safety within the hospital.

7 May 2013

NIH-funded study uncovers novel way that grapes exert beneficial effects in the heart

A study appearing in the Journal of Nutritional Biochemistry- demonstrates that grapes are able to reduce heart failure associated with chronic high blood pressure (hypertension) by increasing the activity of several genes responsible for antioxidant defense in the heart tissue.

3 May 2013

Increased accumulation of coronary artery calcium leads to heart attack risk

Patients with increasing accumulations of coronary artery calcium were more than six times more likely to suffer from a heart attack or die from heart disease than patients who didn't have increasing accumulations, according to a recent study published in the Journal of the American College of Cardiology.

3 May 2013

Heart Failure News and Research

Further Reading

Hospital emergency departments play growing role in US health care system

EHRA EUROPACE 2013 to feature late breaking clinical trials

Heart failure patients may have high risk of death, re-admission after leaving hospital, say researchers

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Simponi injection gets FDA approval to treat adults with ulcerative colitis

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

New studies support previous findings that reducing dietary sodium intake improves health

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

Study shows dual-chamber ICDs are associated with higher risk of device-related complications

Blue Cross Blue Shield Foundation honors Beaumont cardiologist for improving health care in Michigan

Sorin Group receives FDA approval for SMARTVIEW remote monitoring solution

New 3-D technology to see precise source of atrial fibrillation in the heart

Private insurers have cost Medicare almost $300 billion more over the life of the program

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Researchers discover that microRNAs link two defining characteristics of fit muscles

BIOTRONIK receives FDA approval for ICD/CRT-D series

National Transitions of Care Coalition cites patient education as key component of post hospital health management, disease prevention framework

NIH-funded study uncovers novel way that grapes exert beneficial effects in the heart

Increased accumulation of coronary artery calcium leads to heart attack risk

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News